Athena Vale
Muscular dystrophy (MD) is a group of more than 30 genetic conditions that cause progressive muscle weakness and other muscle-related symptoms. The symptoms of MD get worse over time and can be present at birth, develop in childhood, or in adulthood. While there is currently no cure for MD, medications and therapies can slow the progression of the disease and improve a person's quality of life. Researchers are working on developing new treatments, including gene therapies, that may provide hope for people with certain types of MD and may even reverse the disease.
Explore related products
Gene therapy
One of the most promising approaches in gene therapy for muscular dystrophy is the use of adeno-associated viral vectors (AAVs). AAVs are tiny shuttles derived from a virus that can deliver gene therapies directly into muscle cells. This method has been successful in mouse models and has even shown the potential to reverse the muscle wasting associated with dystrophy. The latest approach uses a new type of AAV vector that allows for lower doses, reducing the risk of cancerous transformation related to insertional mutagenesis.
Another key development in gene therapy for muscular dystrophy is the creation of mini- and micro-dystrophin constructs. These constructs are smaller versions of the full-length dystrophin gene, which is too large to fit into a viral vector. The micro-dystrophin version, for example, Elevidys, is designed to deliver a gene that leads to the production of a shortened protein that contains selected domains of the dystrophin protein present in normal muscle cells. This therapy has been approved by the FDA for certain patients with Duchenne Muscular Dystrophy (DMD), a rare and serious form of the disease that primarily affects males.
The goal of gene therapy for muscular dystrophy is to replace the defective genes within the muscles with functional ones. In most gene replacement trials, intramuscular (IM) injections have been used to deliver the therapeutic gene. However, vascular delivery has emerged as a promising alternative as it offers wider distribution of gene expression and is less immunogenic than IM delivery. This method involves catheterization of the femoral artery and vein, followed by the infusion of a saline-based solution to remove unwanted cells from the extremity. The vector carrying the therapeutic gene is then infused and recirculated using a mechanical pump, allowing the gene to reach many muscle groups.
While gene therapy for muscular dystrophy has not been without challenges, the recent approval of the first gene therapy treatment by the FDA represents a monumental advance. This approval provides hope for patients and their families and creates momentum in the field of gene therapy research. As clinical trials continue to advance, there is a sense of urgency to find effective treatments before the irreversible loss of muscle and motor function occurs.
Muscle Milk and Dairy: What's the Deal?
You may want to see also
Explore related products
$119.99 $119.99
Drug treatments
While medication cannot stop or reverse muscular dystrophy, certain drugs can help delay damage to muscles or minimise the symptoms. Corticosteroids, for instance, can improve muscle strength and delay the progression of certain types of muscular dystrophy. However, prolonged use of these drugs can lead to side effects such as weight gain, excessive hair growth, and weakened bones. Examples of corticosteroids include prednisone and deflazacort (Emflaza). Prednisone has been shown to increase muscle strength and respiratory function and slow the progression of weakness in muscular dystrophy. Another corticosteroid, vamorolone, is currently being studied and has shown similar benefits to prednisone without the side effects.
For people with myotonic muscular dystrophy, doctors may prescribe muscle relaxants to relieve muscle spasms. However, these medications may cause side effects such as dizziness, drowsiness, and nausea. Anticonvulsants, typically used for epilepsy, may also help control seizures and some muscle spasms in people with muscular dystrophy.
In recent years, the Food and Drug Administration (FDA) has approved several new drugs for the treatment of specific types of muscular dystrophy. Eteplirsen (Exondys 51) was the first medication approved by the FDA specifically to treat some people with Duchenne muscular dystrophy. It was conditionally approved in 2016, followed by golodirsen (Vyondys 53) in 2019 and viltolarsen in 2020. These treatments require weekly intravenous injections and do not cure Duchenne muscular dystrophy, but they can increase the production of muscle protein. Ataluren is another newer medication developed to treat some children with Duchenne muscular dystrophy who are two years or older and can walk.
Additionally, immunosuppressant drugs, commonly used for autoimmune diseases, may help delay damage to dying muscle cells in muscular dystrophy. Beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and other medications for treating heart problems associated with muscular dystrophy, such as high blood pressure and heart failure, may also be prescribed.
What's Going on With My Muscles?
You may want to see also
Explore related products
Physical therapy
While there is currently no cure for muscular dystrophy, physical therapy can help patients manage their symptoms and improve their quality of life. Muscular dystrophy affects the skeletal muscles that control movement, causing progressive, generalised muscle weakness and atrophy. Physical therapy can help prevent deformities, increase mobility, and keep muscles strong and flexible.
An individualised physical therapy programme is often developed to meet the specific needs of the patient. This may include passive stretching to increase joint flexibility and prevent contractures, as well as range-of-motion exercises to increase muscle strength and prevent the loss of range of motion in joints. It is important to be evaluated by a physical therapist who is familiar with muscular dystrophy, as they can guide you on the correct types of exercise to perform. Some exercises, such as eccentric exercises and resistive/high-load exercises, can be harmful to patients with muscular dystrophy, causing more muscle breakdown. Instead, isometric activities or bodyweight-resisted activities that are appropriately graded to avoid excessive fatigue are more beneficial.
Stretching should be a part of a patient's daily routine and should be guided by their physical therapist. Regular stretching of joints, including the shoulder, elbow, wrist, ankle, knee, and hip, should begin early and continue through adulthood. Bracing and wearing braces or splints at night can help keep the joints in alignment and maintain flexibility and function.
As muscular dystrophy progresses, patients may need to use mobility devices and assistive devices such as canes, walkers, wheelchairs, and splints. A physical therapy team can help evaluate and provide access to the most appropriate devices to optimise the patient's function and quality of life.
Relieving Trapezius Muscle Tension: Simple Tips and Tricks
You may want to see also
Explore related products
Speech therapy
Speech and language therapy can help people with muscular dystrophy manage their symptoms and improve their communication and quality of life. Muscular dystrophy is a congenital, degenerative disease, meaning it is present from birth and gets worse over time. It is caused by a missing gene, which results in a lack of protein necessary for healthy muscle growth and development. This causes muscle weakness and impacts muscle function, including the muscles used for speech and communication.
Speech therapists can help individuals with muscular dystrophy to improve their speech, language, and communication skills. This may include working on articulation training, voice training, and improving the strength and coordination of muscles used for speech. Speech therapists may also recommend alternative and augmentative communication methods, such as gestures, finger spelling, or symbol systems, especially in the later stages of the disease when muscle strengthening alone may not be sufficient. For those with soft voices, devices like voice amplifiers and artificial phonation devices may be recommended.
In addition, speech and language therapy can also address issues with eating, drinking, and swallowing, which can be affected by muscular dystrophy. Speech therapists can work with individuals to improve their ability to perform these daily tasks and recommend adjustments to head and neck position to ease swallowing. They can also provide support and education to the family of the client, allowing for more effective treatment and management of the condition.
The specific approach taken by a speech therapist will depend on the individual's unique symptoms, abilities, challenges, and goals. An initial assessment will be carried out to determine the person's level of communication and devise a therapy plan tailored to their specific needs. This plan may include a range of interventions, such as therapy programmes, support groups, and advice.
Overcoming Heroin Addiction: Building a Strong Mind and Body
You may want to see also
Explore related products
![Cure (The Criterion Collection) [Blu-ray]](https://m.media-amazon.com/images/I/51-TB3dJxZL._AC_UL320_.jpg)
Occupational therapy
Occupational therapists can help patients with daily living activities such as feeding, grooming, dressing, writing, and workplace tasks. They can also teach patients to use assistive devices, such as walkers and wheelchairs, and help them learn new ways to perform job-related tasks. Additionally, occupational therapists can work with caregivers to ensure they know the best ways to offer assistance.
In the case of Duchenne muscular dystrophy (DMD), occupational therapy can help patients maintain and improve the skills needed for managing daily life. OTs can assist patients with motor skills and managing physical tasks, as well as make suggestions for adaptive equipment and modifications for home, school, and work. For example, OTs can recommend the use of a corset to provide better support and balance to the spine in the case of scoliosis. They can also suggest the use of arm slings or orthotic devices to support weak muscles in the wrists, arms, ankles, and shoulders.
The Penis and Muscles: What's the Connection?
You may want to see also
Frequently asked questions
Muscular dystrophy is a group of genetic conditions that cause progressive muscle weakness and other muscle-related symptoms.
The symptoms of muscular dystrophy vary depending on the type, but can include:
- Muscle weakness
- Trouble walking
- Trouble using arms
- Shortening of muscles or tendons around joints
- Inability to relax muscles following contractions
- Drooping eyelids
- Difficulty swallowing
While there is currently no cure for muscular dystrophy, certain medications and therapies can help to slow the progression of the disease and improve quality of life. Gene therapy is also being studied as a potential treatment.
Medications that may be used to treat muscular dystrophy include:
- Glucocorticoids such as prednisone or deflazacort
- Anticonvulsants
- Immunosuppressants
- Beta blockers
- Angiotensin-converting-enzyme (ACE) inhibitors
Gene therapy for muscular dystrophy involves delivering a set of protein packets inside a shuttle vector to replace the defective gene within the muscles. This therapy has shown promise in halting the decline of muscles and may even be able to repair them in the future.
